[Federal Register Volume 77, Number 131 (Monday, July 9, 2012)]
[Notices]
[Pages 40363-40364]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-16641]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-12-12II]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. chapter 35). To request a copy of these requests, call
(404) 639-7570 or send an email to omb@cdc.gov. Send written comments
to CDC Desk Officer, Office of Management and Budget, Washington, DC
20503 or by fax to (202) 395-5806. Written comments should be received
within 30 days of this notice.
Proposed Project
Risk Factors for Invasive Methicillin-resistant Staphylococcus
aureus (MRSA) among Patients Recently Discharged from Acute Care
Hospitals through the Active Bacterial Core Surveillance for Invasive
MRSA infections (ABCs MRSA)--NEW--National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Essential steps in reducing the occurrence of healthcare-associated
invasive MRSA infections are to quantify the burden and to identify
modifiable risk factors associated with invasive MRSA disease. The
current CDC's ABCs MRSA surveillance has been essential to quantify the
burden of invasive MRSA in the United States. Through this surveillance
CDC was able to estimate that 94,360 invasive MRSA infections
associated with 18,650 deaths occurred in the United States in 2005.
The majority of these invasive infections (58%) had onset in the
community or within 3 days of hospital admission and occurred among
individuals with recent healthcare exposures (healthcare-associated
community-onset [HACO]). More recent data from the CDC's ABCs MRSA
system have shown that two thirds of invasive healthcare-associated
community-onset MRSA infections occur among persons who are discharged
from an acute care hospital in the prior 3 months. Risk factors for
invasive MRSA infections post-discharge have not been well evaluated,
and effective prevention measures in this population remain uncertain.
For this project, an estimated total of 450 patients (150 patients
with HACO MRSA infection post-acute care discharge and 300 patients
without HACO MRSA infection) will be contacted for the MRSA interview
annually. This estimate is based on the numbers of MRSA cases reported
by the ABCs MRSA sites annually (http://www.cdc.gov/abcs/reports-findings/survreports/mrsa08.html ) who are 18 years of age or older,
had onset of the MRSA infection in the community or within 3 days of
hospital admission, and history of hospitalization in the prior 3
months. ABCs MRSA surveillance case report forms will be used to
identify HACO MRSA cases to be contacted for a telephone interview. For
each HACO MRSA case identified; 2 patients without HACO MRSA infection
(control-patients) matched on age with MRSA case will be contacted for
a health interview. All 450 patients (both cases and controls) will be
screened for eligibility and those considered to be eligible will
complete the telephone interview. We anticipate that 350 of the 450
patients screened will complete the telephone interview across all 6
participating ABCs MRSA sites per year. We anticipate the screening
questions to take about 5 minutes and the telephone interview 20
minutes per respondent.
Preventing healthcare-associated invasive MRSA infections is one of
CDC priorities. The goal of this project is to assess risk factors for
invasive healthcare-associated MRSA infections, which will inform the
development of targeted prevention measures. This activity supports the
HHS Action Plan for elimination of healthcare-associated infections.
There are no costs to respondents. The total response burden for
the study is estimated as 155 hours.
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Hospital Patients..................... Screening Form.......... 450 1 5/60
Telephone interview..... 350 1 20/60
----------------------------------------------------------------------------------------------------------------
[[Page 40364]]
Kimberly S. Lane,
Deputy Director, Office of Science Integrity, Office of the Associate
Director for Science, Office of the Director, Centers for Disease
Control and Prevention.
[FR Doc. 2012-16641 Filed 7-6-12; 8:45 am]
BILLING CODE 4163-18-P